Lorenzo Ridola - Publications

Beyond portal pressure: what does CIRI really predict?

Journal: Journal of hepatology

Published: July 20, 2026

Lactulose for Preventing Overt Hepatic Encephalopathy: Between Evidence and Unresolved Questions.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 09, 2026

Clinical prediction models in minimal hepatic encephalopathy: how far can they go?

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 06, 2026

Bile Acid Sequestrants in Primary Sclerosing Cholangitis and the Risk of Acute Cholangitis: Cause for Concern?

Journal: Clinical and translational gastroenterology

Published: December 17, 2025

TIPS creation: does portal branch selection really matter?

Journal: Hepatology international

Published: September 23, 2025

Risk Factors Associated with Adenomas or Serrated Polyps in Patients who Underwent Screening Colonoscopy.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: September 11, 2025

Prevention of Portal Hypertension Complications Beyond Primary TIPS Indication Is Independent of Endoprosthesis Under-Dilation.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 26, 2025

Probiotics for Hepatic Encephalopathy Prevention After TIPS: Still an Open Question.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 18, 2025

HBV infection in the era of T-cell engagers in multiple myeloma: unresolved challenges and unmet needs. Comment on: "Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies".

Journal: Haematologica

Published: August 14, 2025

Diagnostic Applications of Artificial Intelligence in Liver Diseases.

Journal: Journal of clinical medicine

Published: July 29, 2025

Rifaximin and survival in cirrhosis: Unmet clinical promise.

Journal: Journal of hepatology

Published: July 18, 2025

Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPS.

Journal: JHEP reports : innovation in hepatology

Published: July 12, 2025